News
The Institue for Precision Medicine and our ongoing work at UPMC and the University of Pittsburgh was featured on ‘AHSG TV’ at the 2018 American Society of Human Genetics conference held in San Diego, California. October 16-20th.
To see the short film produced for this please click here.
UPMC and the University of Pittsburgh today announced the launch of an advanced genome sequencing center to support clinical diagnostics and research initiatives in precision medicine and immunotherapy.
The UPMC Genome Center, established with funding from the recently announced UPMC Immune Transplant and Therapy Center(ITTC) and the Institute for Precision Medicine at UPMC and Pitt,
The University of Pittsburgh and Thermo Fisher Scientific have established a new Pharmacogenomics Center of Excellence in the School of Pharmacy that aims to discover and validate medication response predictors in patients, overcome implementation barriers, and demonstrate the value of genetic testing to guide medication prescribing in routine clinical practice. Pharmacogenomics is the study of how genetic variation impacts medication responses.
The Women-In-Bio Pittsburgh Chapter will highlight Precision Medicine during their annual POWER event on September 26th, 2017. Jennifer Xavier, PhD will represent the IPM in the opening talk before female leaders in Precision Medicine from the Pittsburgh region share their views and experiences. For more information on this event please see the WIB POWER webpage.
The University of Pittsburgh Chancellor Pat Gallagher, Pitt health science faculty researchers, and the Panther men’s basketball team will be in Boston February 6-8.
As part of these events Adrian Lee, PhD, Director, Institute for Precision Medicine will lead a panel discussion on “Machines and Medicine: Partners in Precision Medicine” at MassBio. This event is open to the public.
By Bernie Monegain March 23, 2016 10:24 AM
UPMC Enterprises said it will allocate more than $3 million over the next six months to fund the first half-dozen projects under the Pittsburgh Health Data Alliance.
Pittsburgh, PA (PRWEB) August 31, 2016
As part of its wide-ranging efforts to better target treatments to patients while reducing unnecessary tests and procedures, UPMC announced today that it is investing in and partnering with Cernostics, an oncology diagnostics company whose unique technology enables so-called “precision medicine.”
Through UPMC Enterprises,
Dietrich Stephan, PhD, Associate Director of Population Health and Translational Acceleration, Institute for Precision Medicine and Chair, Department of Human Genetics, University of Pittsburgh, gave the opening keynote lecture at the Inaugural National Precision Medicine Leaders Summit, Aug 10, 2016. Dr Dietrich opened the summit with his presentation entitled “Truth, Friction and the Dream”.
For more information see: www.precisionmedicineleaderssummit.com
President Barack Obama is coming to Pittsburgh this fall to talk about technology and innovation.
The Oct. 13 White House Frontiers Conference, jointly hosted by Pitt, Carnegie Mellon and the White House, will focus on science, technology and innovation, according to a press release from Pitt. WIRED — a magazine focused on trendy technology and its impact — will feature the conference’s topics in its November issue.